Latest Articles

Publication Date
All News Scientific
Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate - Frontiers

Early GnRH-agonist therapy does not negatively impact the endometrial repair process or live birth rate Frontiers

Published: April 29, 2024, 7 a.m.
Read Full Article
Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer - Cancer Health Treatment News

Novel ADC and Immunotherapy Combo Shows Promise for Endometrial Cancer Cancer Health Treatment News

Published: April 9, 2024, 7 a.m.
Read Full Article
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response - Nature.com

Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response Nature.com

Published: April 2, 2024, 7 a.m.
Read Full Article
Matthew A. Powell, MD, on Endometrial Cancer: Overall Survival Update on Dostarlimab-gxly Plus Chemotherapy - The ASCO Post

Matthew A. Powell, MD, on Endometrial Cancer: Overall Survival Update on Dostarlimab-gxly Plus Chemotherapy The ASCO Post

Published: March 27, 2024, 6:45 p.m.
Read Full Article
Magnetic Resonance-Guided Focused Ultrasound Surgery for Gynecologic Indications.

Magnetic resonance-guided focused ultrasound surgery (MRgFUS) appears to be an effective and safe treatment for uterine fibroids and adenomyosis, particularly in women who wish to preserve fertility. In abdominal wall …

Published: March 27, 2024, midnight
Read Full Article
Focused ultrasound surgery Gynecologic indications MRI MRgFUS
Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer - Oncology Learning Network

Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer Oncology Learning Network

Published: March 21, 2024, 7 a.m.
Read Full Article
Immunotherapy Data “Very Much Practice-Changing” in Endometrial Cancer - Oncology News Central

Immunotherapy Data “Very Much Practice-Changing” in Endometrial Cancer Oncology News Central

Published: March 20, 2024, 7 a.m.
Read Full Article
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain - FiercePharma

AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain FiercePharma

Published: March 18, 2024, 7 a.m.
Read Full Article
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor

Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor

Published: March 17, 2024, 7 a.m.
Read Full Article
Comparative efficacy of different growth hormone supplementation protocols in improving clinical outcomes in women with poor ovarian response undergoing assisted reproductive therapy: a network meta-analysis - Nature.com

Comparative efficacy of different growth hormone supplementation protocols in improving clinical outcomes in women with poor ovarian response undergoing assisted reproductive therapy: a network meta-analysis Nature.com

Published: Feb. 9, 2024, 8 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!